{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:22:49Z","timestamp":1789132969372,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jchromb.2021.122529","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T21:13:01Z","timestamp":1610226781000},"page":"122529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Chiral liquid chromatography-tandem mass spectrometry analysis of superwarfarin rodenticide stereoisomers \u2013 Bromadiolone, difenacoum and brodifacoum \u2013 In human plasma"],"prefix":"10.1016","volume":"1165","author":[{"given":"Daniel G.","family":"Nosal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Feinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"van Breemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2021.122529_b0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.19.1.97","article-title":"The discovery of dicumarol and its sequels","volume":"19","author":"Link","year":"1959","journal-title":"Circulation"},{"key":"10.1016\/j.jchromb.2021.122529_b0010","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2141.2008.07119.x","article-title":"The story of the discovery of heparin and warfarin","volume":"141","author":"Wardrop","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jchromb.2021.122529_b0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/188517a0","article-title":"Case of apparent resistance of Rattus norvegicus Berkenhout to anticoagulant poisons","volume":"188","author":"Boyle","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.jchromb.2021.122529_b0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/253275a0","article-title":"Novel 4-hydroxycoumarin anticoagulants active against resistant rats","volume":"253","author":"Hadler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.jchromb.2021.122529_b0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0022172400046969","article-title":"Field trials of difenacoum against warfarin-resistant infestations of Rattus norvegicus","volume":"74","author":"Rennison","year":"1975","journal-title":"J. Hyg. (Lond)"},{"key":"10.1016\/j.jchromb.2021.122529_b0030","first-page":"159","article-title":"Difethialone (LM-2219): a new anticoagulant rodenticide for use against warfarin-resistant and -susceptible strains","volume":"20","author":"Nahas","year":"1988","journal-title":"Ann. Rech. Vet."},{"key":"10.1016\/j.jchromb.2021.122529_b0035","first-page":"399","article-title":"Mechanisms of action of the anticoagulants warfarin, 2-chloro-3-phytylnaphthoquinone (Cl-K), acenocoumarol, brodifacoum and difenacoum in the rabbit","volume":"64","author":"Breckenridge","year":"1978","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jchromb.2021.122529_b0040","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/bi00293a031","article-title":"Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes","volume":"22","author":"Fasco","year":"1983","journal-title":"Biochemistry"},{"key":"10.1016\/j.jchromb.2021.122529_b0045","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1021\/bi00601a003","article-title":"Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition","volume":"17","author":"Whitlon","year":"1978","journal-title":"Biochemistry"},{"key":"10.1016\/j.jchromb.2021.122529_b0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2885.2008.00979.x","article-title":"Pharmacokinetics of eight anticoagulant rodenticides in mice after single oral administration","volume":"31","author":"Vandenbroucke","year":"2008","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2021.122529_b0055","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/archinte.158.17.1929","article-title":"Superwarfarin poisoning","volume":"158","author":"Chua","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jchromb.2021.122529_b0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/nyas.13085","article-title":"The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures","volume":"1374","author":"Feinstein","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jchromb.2021.122529_b0065","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/jat\/29.6.556","article-title":"Detection of anticoagulant residues by a new HPLC method in specimens of poisoned animals and a poison control case study","volume":"29","author":"Meiser","year":"2005","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122529_b0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.toxlet.2017.01.004","article-title":"Brodifacoum poisoning: a clear and present danger to public health in the USA","volume":"268","author":"Feinstein","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jchromb.2021.122529_b0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tmrv.2015.06.002","article-title":"Long-acting anticoagulant rodenticide (superwarfarin) poisoning: a review of its historical development, epidemiology, and clinical management","volume":"29","author":"King","year":"2015","journal-title":"Transfus. Med. Rev."},{"issue":"2019","key":"10.1016\/j.jchromb.2021.122529_b0080","first-page":"1220","article-title":"Annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 36th annual report","volume":"57","author":"Gummin","year":"2018","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122529_b0085","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa1807652","article-title":"An outbreak of synthetic cannabinoid\u2013associated coagulopathy in Illinois","volume":"379","author":"Kelkar","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jchromb.2021.122529_b0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.7326\/L19-0321","article-title":"Coagulopathy after synthetic cannabinoid use: a case report","volume":"171","author":"Rasin","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jchromb.2021.122529_b0095","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.bpj.2016.03.004","article-title":"Membrane cholesterol modulates superwarfarin toxicity","volume":"110","author":"Marangoni","year":"2016","journal-title":"Biophys. J."},{"key":"10.1016\/j.jchromb.2021.122529_b0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/toxsci\/kfx134","article-title":"The long-lasting rodenticide brodifacoum induces neuropathology in adult male rats","volume":"159","author":"Kalinin","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jchromb.2021.122529_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/toxsci\/kfy147","article-title":"The bile sequestrant cholestyramine increases survival in a rabbit model of brodifacoum poisoning","volume":"165","author":"Lindeblad","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jchromb.2021.122529_b0110","doi-asserted-by":"crossref","first-page":"16779","DOI":"10.1038\/s41598-019-53299-8","article-title":"Efficacy of rodenticide baits with decreased concentrations of brodifacoum: validation of the impact of the new EU anticoagulant regulation","volume":"9","author":"Frankova","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jchromb.2021.122529_b0115","unstructured":"A. Brutlag, K. Benson, Breaking News! D-CON\u00ae Rodenticide ingredient changes to vitamin D3 (2018). Available from: <https:\/\/www.petpoisonhelpline.com\/veterinarian-tips\/breaking-news-d-con-rodenticide-ingredient-changes-to-vitamin-d3\/> (accessed December 28, 2020)."},{"key":"10.1016\/j.jchromb.2021.122529_b0120","unstructured":"G. Witmer, K. Horak, R. Moulton, R. Baldwin, New rodenticides: an update on recent research trials, in: 15th Wildl. Damage Manag. Conf., 2013, pp. 79\u201385. Available from: <https:\/\/digitalcommons.unl.edu\/cgi\/viewcontent.cgi?article=2426&context=icwdm_usdanwrc>."},{"key":"10.1016\/j.jchromb.2021.122529_b0125","article-title":"Cage efficacy grials with cholecalciferol plus diphacinone and cholecalciferol plus brodifacoum baits using Richardson\u2019s ground squirrels","volume":"28","author":"Witmer","year":"2018","journal-title":"Proc. Vertebr. Pest Conf."},{"key":"10.1016\/j.jchromb.2021.122529_b0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/03014223.2019.1657473","article-title":"Diphacinone with cholecalciferol for controlling possums and ship rats","volume":"47","author":"Eason","year":"2020","journal-title":"N. Z. J. Zool."},{"key":"10.1016\/j.jchromb.2021.122529_b0135","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1124\/dmd.116.071688","article-title":"Development of an ecofriendly anticoagulant rodenticide based on the stereochemistry of difenacoum","volume":"44","author":"Damin-Pernik","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122529_b0140","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ps.5155","article-title":"The stereoisomerism of second generation anticoagulant rodenticides: a way to improve this class of molecules to meet the requirements of society?","volume":"75","author":"Lattard","year":"2019","journal-title":"Pest Manag. Sci."},{"key":"10.1016\/j.jchromb.2021.122529_b0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1124\/dmd.116.073791","article-title":"Management of rodent ropulations by anticoagulant rodenticides: toward third-generation anticoagulant rodenticides","volume":"45","author":"Damin-Pernik","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2021.122529_b0150","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00204-020-02662-0","article-title":"Comparative biological properties of the four stereoisomers of difethialone, a second-generation anticoagulant rodenticide, in rats: development of a model allowing to choose the appropriate stereoisomeric ratio","volume":"94","author":"Lefebvre","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122529_b0155","doi-asserted-by":"crossref","unstructured":"M.G. Nilos, J. Gan, D. Schlenk, Effects of chirality on toxicity, in: Gen. Appl. Toxicol., John Wiley & Sons, Ltd, Chichester, UK, 2009, https:\/\/doi.org\/10.1002\/9780470744307.gat031.","DOI":"10.1002\/9780470744307.gat031"},{"key":"10.1016\/j.jchromb.2021.122529_b0160","doi-asserted-by":"crossref","first-page":"85","DOI":"10.59566\/IJBS.2006.2085","article-title":"Chiral drugs: an overview","volume":"2","author":"Nguyen","year":"2006","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.jchromb.2021.122529_b0165","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2125.1986.tb02966.x","article-title":"Enantiomers of warfarin and vitamin K1 metabolism","volume":"22","author":"Choonara","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2021.122529_b0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00002018-199308020-00005","article-title":"Stereoisomers and drug toxicity","volume":"8","author":"Scott","year":"1993","journal-title":"Drug Saf."},{"key":"10.1016\/j.jchromb.2021.122529_b0175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/cpt1976203342","article-title":"The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies","volume":"20","author":"Jahnchen","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2021.122529_b0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jchromb.2016.12.028","article-title":"Core-shell LC-MS\/MS method for quantification of second generation anticoagulant rodenticides diastereoisomers in rat liver in relationship with exposure of wild rats","volume":"1041\u20131042","author":"Fourel","year":"2017","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed Life Sci."},{"key":"10.1016\/j.jchromb.2021.122529_b0185","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0021-9673(01)90444-3","article-title":"High-performance liquid chromatographic strategies for the determination and confirmation of anticoagulant rodenticide residues in animal tissues","volume":"321","author":"Hunter","year":"1985","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jchromb.2021.122529_b0190","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.toxlet.2019.02.011","article-title":"The relative toxicity of brodifacoum enantiomers","volume":"306","author":"Feinstein","year":"2019","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jchromb.2021.122529_b0195","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/jaoacint\/qsaa007","article-title":"Separation and quantification of superwarfarin rodenticide diastereomers\u2014bromadiolone, difenacoum, flocoumafen, brodifacoum, and difethialone\u2014in human plasma","volume":"103","author":"Nosal","year":"2020","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jchromb.2021.122529_b0200","first-page":"1","article-title":"An outbreak of severe coagulopathy from synthetic cannabinoids tainted with long-acting anticoagulant rodenticides","author":"Devgun","year":"2019","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122529_b0205","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/15563650.2019.1687903","article-title":"Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids","volume":"58","author":"Feinstein","year":"2020","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122529_b0210","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.mayocp.2018.05.005","article-title":"An outbreak of brodifacoum coagulopathy due to synthetic marijuana in central Illinois","volume":"93","author":"Hussain","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jchromb.2021.122529_b0215","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/jat\/bkw008","article-title":"LC-MS-MS analysis of brodifacoum isomers in rat tissue","volume":"40","author":"Hauck","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2021.122529_b0220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/(SICI)1096-9063(199607)47:3<225::AID-PS407>3.0.CO;2-P","article-title":"Monitoring the exposure of barn owls to second-generation rodenticides in southern Eire","volume":"47","author":"Eadsforth","year":"1996","journal-title":"Pestic. Sci."},{"key":"10.1016\/j.jchromb.2021.122529_b0225","article-title":"More Practical Problem Solving in HPLC","author":"Kromidas","year":"2004","journal-title":"Wiley"},{"key":"10.1016\/j.jchromb.2021.122529_b0230","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0731-7085(01)00646-X","article-title":"Reversal of elution order during the chiral separation in high performance liquid chromatography","volume":"27","author":"Okamoto","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2021.122529_b0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0021-9673(00)00949-3","article-title":"Unusual effects of separation conditions on chiral separations","volume":"906","author":"Persson","year":"2001","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2021.122529_b0240","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/0584-8547(84)80189-5","article-title":"Calibration and curve fitting for extended range AAS","volume":"39","author":"Miller-Ihli","year":"1984","journal-title":"Spectrochim. Acta Part B At. Spectrosc."},{"key":"10.1016\/j.jchromb.2021.122529_b0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1872312811206030002","article-title":"Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarins","volume":"6","author":"Kim","year":"2012","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.jchromb.2021.122529_b0250","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.2042-7158.1973.tb09133.x","article-title":"Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man","volume":"25","author":"Hewick","year":"1973","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jchromb.2021.122529_b0255","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/cpt1974154424","article-title":"Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man","volume":"15","author":"Breckenridge","year":"1974","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2021.122529_b0260","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.scitotenv.2017.08.117","article-title":"Accumulation of anticoagulant rodenticides (chlorophacinone, bromadiolone and brodifacoum) in a non-target invertebrate, the slug, Deroceras reticulatum","volume":"610\u2013611","author":"Alomar","year":"2018","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.jchromb.2021.122529_b0265","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jspr.2018.08.006","article-title":"Brodifacoum as a first choice rodenticide for controlling bromadiolone-resistant Mus musculus","volume":"79","author":"Bla\u017ei\u0107","year":"2018","journal-title":"J. Stored Prod. Res."},{"key":"10.1016\/j.jchromb.2021.122529_b0270","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2885.2004.00600.x","article-title":"Plasma terminal half-life","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:03:53Z","timestamp":1761606233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023221000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":54,"alternative-id":["S1570023221000088"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122529","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chiral liquid chromatography-tandem mass spectrometry analysis of superwarfarin rodenticide stereoisomers \u2013 Bromadiolone, difenacoum and brodifacoum \u2013 In human plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122529"}}